Hippocampal neuronal apoptosis in type 1 diabetes
- PMID: 12137925
- DOI: 10.1016/s0006-8993(02)02887-1
Hippocampal neuronal apoptosis in type 1 diabetes
Abstract
Duration-related cognitive impairment is an increasingly recognized complication of type 1 diabetes. To explore potential underlying mechanisms, we examined hippocampal abnormalities in the spontaneously type 1 diabetic BB/W rat. As a functional assay of cognition, the Morris water maze test showed significantly prolonged latencies in 8-month diabetic rats not present at 2 months of diabetes. These abnormalities were associated with DNA fragmentation, positive TUNEL staining, elevated Bax/Bcl-x(L) ratio, increased caspase 3 activities and decreased neuronal densities in diabetic hippocampi. These changes were not caused by hypoglycemic episodes or reduced weight in diabetic animals. To explore potential mechanisms responsible for the apoptosis, we examined the expression of the IGF system. Western blotting and in situ hybridization revealed significant reductions in the expression of IGF-I, IGF-II, IGF-IR and IR preceding (2 months) and accompanying (8 months) the functional cognitive impairments and the apoptotic neuronal loss in hippocampus. These data suggest that a duration-related apoptosis-induced neuronal loss occurs in type 1 diabetes associated with cognitive impairment. The data also suggest that this is at least in part related to impaired insulin and/or IGF activities.
Similar articles
-
The role of impaired insulin/IGF action in primary diabetic encephalopathy.Brain Res. 2005 Mar 10;1037(1-2):12-24. doi: 10.1016/j.brainres.2004.11.063. Brain Res. 2005. PMID: 15777748
-
The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats.Diabetes. 2005 May;54(5):1497-505. doi: 10.2337/diabetes.54.5.1497. Diabetes. 2005. PMID: 15855338
-
C-peptide prevents hippocampal apoptosis in type 1 diabetes.Int J Exp Diabetes Res. 2002 Oct-Dec;3(4):241-5. doi: 10.1080/15604280214936. Int J Exp Diabetes Res. 2002. PMID: 12546277 Free PMC article.
-
Current status of clinical and experimental researches on cognitive impairment in diabetes.Chin J Integr Med. 2006 Mar;12(1):68-74. doi: 10.1007/BF02857437. Chin J Integr Med. 2006. PMID: 16571291 Review.
-
The Effect of Diabetes Mellitus on Apoptosis in Hippocampus: Cellular and Molecular Aspects.Int J Prev Med. 2016 Mar 10;7:57. doi: 10.4103/2008-7802.178531. eCollection 2016. Int J Prev Med. 2016. PMID: 27076895 Free PMC article. Review.
Cited by
-
The relationship between diabetes and the dementia risk: a meta-analysis.Diabetol Metab Syndr. 2024 May 14;16(1):101. doi: 10.1186/s13098-024-01346-4. Diabetol Metab Syndr. 2024. PMID: 38745237 Free PMC article. Review.
-
Mechanistic Insights and Potential Therapeutic Implications of NRF2 in Diabetic Encephalopathy.Mol Neurobiol. 2024 Mar 14. doi: 10.1007/s12035-024-04097-5. Online ahead of print. Mol Neurobiol. 2024. PMID: 38483656 Review.
-
Affective and Cognitive Impairments in Rodent Models of Diabetes.Curr Neuropharmacol. 2024;22(8):1327-1343. doi: 10.2174/1570159X22666240124164804. Curr Neuropharmacol. 2024. PMID: 38279738 Review.
-
"Adjust Zang and arouse spirit" electroacupuncture ameliorates cognitive impairment by reducing endoplasmic reticulum stress in db/db mice.Front Endocrinol (Lausanne). 2023 Apr 19;14:1185022. doi: 10.3389/fendo.2023.1185022. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37152933 Free PMC article.
-
Is metformin neuroprotective against diabetes mellitus-induced neurodegeneration? An updated graphical review of molecular basis.Pharmacol Rep. 2023 Jun;75(3):511-543. doi: 10.1007/s43440-023-00469-1. Epub 2023 Apr 24. Pharmacol Rep. 2023. PMID: 37093496 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials